Title
Review: In type 2 diabetes, SGLT-2 inhibitors or GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors
Date Issued
17 July 2018
Access level
metadata only access
Resource Type
journal article
Author(s)
Egan A.M.
Publisher(s)
NLM (Medline)
Start page
JC2
Volume
169
Issue
2
Language
English
OCDE Knowledge area
Endocrinología, Metabolismo (incluyendo diabetes, hormonas)
Publication version
Version of Record
Scopus EID
2-s2.0-85071355324
PubMed ID
Source
Annals of internal medicine
ISSN of the container
15393704
Sources of information:
Directorio de Producción Científica
Scopus